Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288)
Condition: AsthmaInterventions: Drug: montelukast sodium; Drug: placeboSponsor: Merck Sharp & Dohme Corp.Completed - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2004 Category: Research Source Type: clinical trials
Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)
Conditions: Asthma, Bronchial; Rhinitis, Allergic, PerennialInterventions: Drug: MK0476, montelukast sodium; Drug: Comparator: placeboSponsor: Merck Sharp & Dohme Corp.Completed - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2004 Category: Research Source Type: clinical trials